Alzheimer’s Research & Therapy (Sep 2018)

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

  • Susanne Ostrowitzki,
  • Robert A. Lasser,
  • Ernest Dorflinger,
  • Philip Scheltens,
  • Frederik Barkhof,
  • Tania Nikolcheva,
  • Elizabeth Ashford,
  • Sylvie Retout,
  • Carsten Hofmann,
  • Paul Delmar,
  • Gregory Klein,
  • Mirjana Andjelkovic,
  • Bruno Dubois,
  • Mercè Boada,
  • Kaj Blennow,
  • Luca Santarelli,
  • Paulo Fontoura,
  • for the SCarlet RoAD Investigators

DOI
https://doi.org/10.1186/s13195-018-0409-4
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 1

Abstract

Read online

Following publication of the original article [1], the author reported errors in the formatting of the table. The details of the errors are as follows: